Visit PubMed URL
Start discussion

Related resources

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

COVID-19 and missed routine immunizations: designing for effective catch-up in Canada

COVID-19: Impact on routine childhood vaccination uptake in Australia A report by the National Centre for Immunisation Research and Surveillance using data from the Australian Immunisation Register

Covid-19 and its impact on immunization programs: reflections from Brazil

The performance of routine immunization in selected African countries during the first six months of the COVID-19 pandemic

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis

The coronavirus disease 2019 (COVID-19) pandemic has significantly affected utilization of preventative health care, including vaccines. We aimed to assess HPV vaccination rates during the pandemic, and conduct a simulation model-based analysis to estimate the impact of current coverage and future pandemic recovery scenarios on disease outcomes. The model population included females and males of all ages in the US. The model compares pre-COVID vaccine uptake to 3 reduced coverage scenarios with varying recovery speed. Vaccine coverage was obtained from Truven Marketscan™. Substantially reduced coverage between March-August 2020 was observed compared to 2018-2019. The model predicted that 130,853 to 213,926 additional cases of genital warts; 22,503 to 48,157 cases of CIN1; 48,682 to 110,192 cases of CIN2/3; and 2,882 to 6,487 cases of cervical cancer will occur over the next 100 years, compared to status quo. Providers should plan efforts to recover HPV vaccination and minimize potential long-term consequenc

2021
HPV
Vaccine
12
39
Added by: Moderator
Added on: 11 May, 2021
Hits: 508